| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/13/2008 | US20080064112 Method for performing a non-invasive blood gas test |
| 03/13/2008 | US20080064111 Methods for diagnosing a gastrointestinal disorder in an individual |
| 03/13/2008 | US20080064104 Antagonists and agonists of ldcam and methods of use |
| 03/13/2008 | US20080064103 Identifying regulatory compounds which dissociate/destsbilize receptor/ligand binding activity; for use in controlled immune suppression |
| 03/13/2008 | US20080064101 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| 03/13/2008 | US20080064096 Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
| 03/13/2008 | US20080064060 Major histocompatibility complex proteins for use in tissue targeted therapy of tumor antigens; diagnosing organ transplant rejection |
| 03/13/2008 | US20080064056 Function homology screening |
| 03/13/2008 | US20080064055 Methods for the identification, assessment, and treatment of patients with cancer therapy |
| 03/13/2008 | US20080064052 Crystal of a Receptor-Ligand Complex and methods of use |
| 03/13/2008 | US20080064051 Method of Diagnosing Tuberculosis |
| 03/13/2008 | US20080064050 Applications of the binding interaction of proanthocyanidins with bacteria and bacterial components |
| 03/13/2008 | US20080064049 Compositions and methods for treating and diagnosing cancer |
| 03/13/2008 | US20080064048 Using ubiquitin specific immunoglobulins to identify and harvest nervous system tissues; tissue targeted therapy; antitumor agents |
| 03/13/2008 | US20080064047 Using presence of cystatin B, chaperonin 10 and/or profilin as predicitive indicators of cell proliferative disorders |
| 03/13/2008 | US20080064046 Using rat dorsal root receptor (DRR) and displacement of adrenal medulla docosapeptide (BAM-22P) as tools identifying modulators for prevention and treatment of pain, neuropathic and inflammatory disorders |
| 03/13/2008 | US20080064045 Biomarker fragments for the detection of human BNP |
| 03/13/2008 | US20080064044 Using somatomedin concentration as diagnostic/prognostic tool in detection of prostate and/or breast cancers |
| 03/13/2008 | US20080064043 Using cytosine methylation as tool in detection of cell proliferative disorders; gene expression analysis; genetic imprinting |
| 03/13/2008 | US20080064041 Biomap analysis |
| 03/13/2008 | US20080064040 Monitoring gene silencing and annotating gene function in living cells |
| 03/13/2008 | US20080064039 Dominant negative ligand drug discovery system |
| 03/13/2008 | US20080064036 P75ntr Screening Assay |
| 03/13/2008 | US20080064035 Method For Determining Biophysical Properties |
| 03/13/2008 | US20080064034 Multi-Cellular Test Systems |
| 03/13/2008 | US20080064032 Polynucleotides and uses thereof |
| 03/13/2008 | US20080064027 Using translocation-ETS-leukemia (TEL) gene products as tool in identifying modulators of cell proliferative disorders |
| 03/13/2008 | US20080064025 Using nanoscale, self-signaling, antibody biosensors for use in single-step detection of preferential particle in solution |
| 03/13/2008 | US20080064023 Oligomer Probe Array with Improved Signal-to-Noise Ratio Fabrication Method Thereof |
| 03/13/2008 | US20080063794 Attaching a linker to the array of microelectrodes; adding a porogen and a polymerization solution, polymerizing to form a permeation layer attached to the surface of the array through the linker; removing the porogen; active electronic matrix devices for biological assays |
| 03/13/2008 | US20080063655 nucleic acid sequences encoding a 30 kD Brachyspira hyodysenteriae lipoprotein; host cell; new locus comprising four genes has now surprisingly been found; swine dysentery |
| 03/13/2008 | US20080063643 HLA-binding motif in its sequence; recognized by an HLA-A2- or HLA-A24-restricted cytotoxic T cell; nucleotide; antibody; vector; diagnosid and prognosis of hepatitis C virus infection |
| 03/13/2008 | US20080063640 Pin-Prc Transition Genes |
| 03/13/2008 | US20080063636 polypeptides having deletions in the amino acid sequence, useful as antigens for improving vaccine therapy; treatment of Alzheimer's disease |
| 03/13/2008 | US20080063634 genetic engineered antibody or antigen binding segment that is capable of binding to interleukins and altering the conformation structure, used for treating diseases involving immune and inflammatory responses |
| 03/13/2008 | US20080063630 polynucleotides that code for polypeptides having activity for targeting heterogeneous polypeptides to the surfaces of cytoplasmic membranes, useful for analysis of proteind, delivery of cells expressing the polypeptide to a target site in vivo, preparation of an antibodies and vaccines, and gene therapy |
| 03/13/2008 | US20080063600 use of deactivated lymphocytes, antibodies, drug mixtures and adjuvants, for the treatment or prevention of Cruetzfield-Jacobs disease in humans or animals; immunology; bioassays |
| 03/13/2008 | US20080063598 chimeric antibodies, fragments, polypeptides and derivatives that preferentially bind tumor associated antigens (AF-20), useful in the treatment and diagnosis of cancers |
| 03/13/2008 | US20080063564 Multiple acid solution characterization |
| 03/13/2008 | US20080063562 Parallel gripper for handling multiwell plate. |
| 03/13/2008 | US20080062839 Optical disc analysis system including related methods for biological and medical imaging |
| 03/13/2008 | US20080060944 Electrophoresis apparatus having an outlet passage |
| 03/13/2008 | US20080060940 Base sequence detection apparatus and base sequence automatic analyzing apparatus |
| 03/13/2008 | US20080060424 Test element for analyzing body fluids |
| 03/13/2008 | US20080060422 Examination element and examination container |
| 03/13/2008 | US20080060409 Breath Test Simulator |
| 03/13/2008 | US20080060408 Breath test simulator |
| 03/13/2008 | DE112004002217T5 Proteinbildungskomplex mit einem c-Jun-Protein, Nucleinsäure, codierend denselben und Verfahren unter Verwendung desselben The same protein complex formation with a c-Jun protein, nucleic acid encoding the same and methods using |
| 03/13/2008 | DE102006040444A1 Verfahren zur Probenvorbereitung für die quantitative Analyse von Aminosäuren enthaltenden Proben Process for the preparation of samples for quantitative analysis of amino acids containing samples |
| 03/13/2008 | DE102005000831B4 Kontaminations-Überwachungsvorrichtung, Kontaminations-Managementsystem und darauf bezogene Verfahren Contamination Monitoring device, contamination management system and related methods |
| 03/13/2008 | CA2698597A1 Monitoring cancer stem cells |
| 03/13/2008 | CA2698583A1 Cancer stem cell-targeted cancer therapy |
| 03/13/2008 | CA2663390A1 Method for study, determination or evaluation by gene expression analysis |
| 03/13/2008 | CA2662863A1 Methods and compositions for the detection of protein folding disorders |
| 03/13/2008 | CA2662859A1 Methods for ranking cellular images |
| 03/13/2008 | CA2662723A1 Means and methods for the production of amyloid oligomers |
| 03/13/2008 | CA2662624A1 Fluorescent cell markers |
| 03/13/2008 | CA2662597A1 Biomarkers for assessing liver function |
| 03/13/2008 | CA2662573A1 Three-phase cyclonic fluid separator with a debris trap |
| 03/13/2008 | CA2662501A1 Methods of predicting distant metastasis of lymph node-negative primary breast cancer using biological pathway gene expression analysis |
| 03/13/2008 | CA2662429A1 Ip-10 based immunological monitoring |
| 03/13/2008 | CA2662341A1 Methods and kits for detecting cerebrospinal fluid in a sample |
| 03/13/2008 | CA2662335A1 Methods for designing parp inhibitors and uses thereof |
| 03/13/2008 | CA2662323A1 Assay for antibodies to mycobacterium paratuberculosis |
| 03/13/2008 | CA2662041A1 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders |
| 03/13/2008 | CA2661633A1 Molecular diagnosis and classification of malignant melanoma |
| 03/13/2008 | CA2661332A1 Compositions and methods for diagnosis and treatment of type 2 diabetes |
| 03/13/2008 | CA2661308A1 Neukinase, a downstream protein of neuregulin |
| 03/13/2008 | CA2656227A1 Cancer therapeutic agents comprising a ligand for the neuromedin u receptor 2 (fm4) molecule as an active ingredient |
| 03/12/2008 | EP1898222A1 Cartridge |
| 03/12/2008 | EP1898216A2 Diagnostic reagent and diagnostic reagent kit for HIV infection, method for manufacturing diagnostic reagent for HIV infection and method for detecting anti-HIV antibody |
| 03/12/2008 | EP1898215A1 Method of assaying endocrine substance in specimen |
| 03/12/2008 | EP1898207A1 Method and apparatus for measuring intensity of laid lines in a strip-like product |
| 03/12/2008 | EP1897949A2 Human interleukin-B50. Therapeutic uses |
| 03/12/2008 | EP1897947A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897946A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897945A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897944A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897943A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897940A1 Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer |
| 03/12/2008 | EP1897889A2 Method of modulating the profileration of medullary thyroid carcinoma cells |
| 03/12/2008 | EP1897617A1 Centrifugal force-based microfluidic device for protein detection and microfluidic system including the same |
| 03/12/2008 | EP1897548A1 T cell regulation |
| 03/12/2008 | EP1897540A2 Inhibition of STAT3 signal transduction for human cancer therapy |
| 03/12/2008 | EP1897014A1 Apparatus and method for analyzing a metabolite profile |
| 03/12/2008 | EP1896857A1 A method for separating target component using magnetic nanoparticles |
| 03/12/2008 | EP1896856A1 Polypeptide marker for detecting the rejection of transplanted kidneys at an early stage |
| 03/12/2008 | EP1896855A2 Biomarkers for breast cancer |
| 03/12/2008 | EP1896854A1 Combinations of tumor-associated antigens in diagnostics for various types of cancer |
| 03/12/2008 | EP1896853A1 Carrier material, method for the production and use thereof |
| 03/12/2008 | EP1896852A2 Apparatus for moving magnetic particles |
| 03/12/2008 | EP1896851A1 Membrane array and analytical device |
| 03/12/2008 | EP1896849A2 Antibodies against histone modifications for clinical diagnosis and prognosis of cancer |
| 03/12/2008 | EP1896848A2 Diagnosis of tuberculosis |
| 03/12/2008 | EP1896847A1 Carbon nanotube transistor biosensors with aptamers as molecular recognition elements and method for sensing a target material using the same |
| 03/12/2008 | EP1896846A2 Analysis method for determining a functional parameter of an organ using preferably an aqueous 13c methacetin solution |
| 03/12/2008 | EP1896844A1 Method for procyanidin analysis |
| 03/12/2008 | EP1896843A2 Ratiometric test strip and method |
| 03/12/2008 | EP1896841A2 Gas phase chemical sensor based on film bulk resonators (fbar) |
| 03/12/2008 | EP1896832A2 Metal-enhanced fluorescence-based sensing methods |